Non‐serious adverse events (secondary outcome) · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether non‐absorbable disaccharides changes non‐serious adverse events (secondary outcome) compared with placebo/no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether lactulose changes mortality compared with lactitol (very low certainty).
1 finding from 1 review
Hepatic encephalopathy · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether lactulose changes hepatic encephalopathy compared with lactitol (very low certainty).
1 finding from 1 review
Serious adverse events · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether lactulose changes serious adverse events compared with lactitol (very low certainty).
1 finding from 1 review
Secondary outcome: quality of life · prevention and treatment of hepatic encephalopathy in people with cirrhosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Lack of pain relief · people with biliary colic
Non‐steroid anti‐inflammatory drugs probably leads to lower lack of pain relief compared with placebo (moderate certainty).
1 finding from 1 review
Cholelithiasis‐related complications · people with biliary colic
It is very uncertain whether non‐steroid anti‐inflammatory drugs changes cholelithiasis‐related complications compared with placebo (very low certainty).
1 finding from 1 review
Lack of pain relief · people with biliary colic
It is very uncertain whether non‐steroid anti‐inflammatory drugs changes lack of pain relief compared with opioids (very low certainty).
1 finding from 1 review
Cholelithiasis‐related complications · people with biliary colic
It is very uncertain whether non‐steroid anti‐inflammatory drugs changes cholelithiasis‐related complications compared with opioids (very low certainty).
1 finding from 1 review
Lack of pain relief · people with biliary colic
Non‐steroid anti‐inflammatory drugs may leads to lower lack of pain relief compared with spasmolytic drugs (low certainty).
1 finding from 1 review
Cholelithiasis‐related complications · people with biliary colic
Non‐steroid anti‐inflammatory drugs may leads to lower cholelithiasis‐related complications compared with spasmolytic drugs (low certainty).
1 finding from 1 review
Intervention not reported
There was no evidence of differences in the proportion of participants experiencing serious adverse events (for any of the comparisons Quality of evidence = very low1,2,3. · people undergoing liver resection
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
There was no evidence of differences in the number of serious adverse events for any of the comparisons Quality of evidence = very low1,2,3. · people undergoing liver resection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
None of the trials reported this outcome at any time point. · people undergoing liver resection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
PEI versus PAI · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Recurrence‐free survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Number and type of adverse events · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Duration of hospital stay · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
125 participants
Very low
Intervention not reported
Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found